242 related articles for article (PubMed ID: 35572595)
21. Immune cell infiltration-associated signature in colon cancer and its prognostic implications.
Deng D; Luo X; Zhang S; Xu Z
Aging (Albany NY); 2021 Aug; 13(15):19696-19709. PubMed ID: 34349038
[TBL] [Abstract][Full Text] [Related]
22. Mapping the immunological battlefield in gastric cancer: prognostic implications of an immune gene expression signature.
Meng X; Wang D; Sun X; Yuan J; Han J
Discov Oncol; 2023 Nov; 14(1):212. PubMed ID: 37999824
[TBL] [Abstract][Full Text] [Related]
23. An immune-related gene prognostic risk index for pancreatic adenocarcinoma.
Su Y; Qi R; Li L; Wang X; Li S; Zhao X; Hou R; Ma W; Liu D; Zheng J; Shi M
Front Immunol; 2022; 13():945878. PubMed ID: 35958614
[TBL] [Abstract][Full Text] [Related]
24. Immune-related gene prognostic index (IRGPI) for lung adenocarcinoma predicts patient prognosis and immunotherapy response.
Zhu Z; Feng W; Tan XY; Gu PC; Song W; Ma HT
Int J Clin Exp Pathol; 2023; 16(10):260-281. PubMed ID: 37970331
[TBL] [Abstract][Full Text] [Related]
25. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
Liao Y; He D; Wen F
Immunogenetics; 2021 Oct; 73(5):369-380. PubMed ID: 34302518
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Sun D; Yang KS; Chen JL; Wang ZB
World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
[TBL] [Abstract][Full Text] [Related]
27. An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment.
Wang X; Su W; Tang D; Jing J; Xiong J; Deng Y; Liu H; Ma W; Liu Z; Zhang Q
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771505
[TBL] [Abstract][Full Text] [Related]
28. An Apoptosis-Related Gene Prognostic Index for Colon Cancer.
Tang H; Wang J; Luo X; Wang Q; Chen J; Zhang X; Li Q; Gao C; Li Y; Han S
Front Cell Dev Biol; 2021; 9():790878. PubMed ID: 34957118
[No Abstract] [Full Text] [Related]
29. Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer.
Zhang Q; Feng Z; Zhang Y; Shi S; Zhang Y; Ren S
Biomed Res Int; 2021; 2021():6057948. PubMed ID: 34124251
[TBL] [Abstract][Full Text] [Related]
30. A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies.
Xu Y; Chen Y; Niu Z; Xing J; Yang Z; Yin X; Guo L; Zhang Q; Qiu H; Han Y
Front Med (Lausanne); 2022; 9():841568. PubMed ID: 35492358
[TBL] [Abstract][Full Text] [Related]
31. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options.
Xue W; Dong B; Wang Y; Xie Y; Li P; Gong Z; Niu Z
Exp Mol Pathol; 2022 Oct; 128():104832. PubMed ID: 36122795
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and immunotherapy response prediction based on M2 macrophage-related genes in colon cancer.
Xu X; Zhang X; Kou R; Liu Y; Chen S; Li Z; Jian Z; Wang Z
J Cancer Res Clin Oncol; 2024 Jan; 150(2):31. PubMed ID: 38270646
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of drug sensitivity, immunological characteristics, and prognosis in melanoma patients using an endoplasmic reticulum stress-associated signature based on bioinformatics and pan-cancer analysis.
Hounye AH; Hu B; Wang Z; Wang J; Cao C; Zhang J; Hou M; Qi M
J Mol Med (Berl); 2023 Oct; 101(10):1267-1287. PubMed ID: 37653150
[TBL] [Abstract][Full Text] [Related]
34. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
[TBL] [Abstract][Full Text] [Related]
35. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
36. Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy.
Qu J; Sun F; Hou Y; Qi H; Sun X; Xing L
BMC Cancer; 2023 Jun; 23(1):549. PubMed ID: 37322434
[TBL] [Abstract][Full Text] [Related]
37. Development of a prognostic index of colon adenocarcinoma based on immunogenomic landscape analysis.
Qiang W; Dai Y; Sun G; Xing X; Sun X
Ann Transl Med; 2020 Mar; 8(6):284. PubMed ID: 32355728
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
39. Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes.
Zhou R; Gao Z; Ju Y
BMC Bioinformatics; 2022 Oct; 23(1):418. PubMed ID: 36221049
[TBL] [Abstract][Full Text] [Related]
40. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
Li X; Wen D; Li X; Yao C; Chong W; Chen H
Front Immunol; 2020; 11():1678. PubMed ID: 33013820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
